The Types dimension categorizes Tissue Imaging technologies into six sub‑types: Optical Imaging, Magnetic Resonance Imaging (MRI), Positron Emission Tomography (PET), Computed Tomography (CT), Ultrasound, and Mass Spectrometry Imaging (MSI). Optical Imaging—including fluorescence, confocal, and multiphoton modalities—dominates due to its high spatial resolution and compatibility with multiplexed labeling. MRI offers deep tissue contrast without ionizing radiation, supporting both anatomical and functional studies, while PET provides quantitative metabolic mapping, essential for oncology and neurology research. CT contributes rapid, high‑throughput volumetric data, particularly in preclinical models. Ultrasound delivers real‑time, cost‑effective imaging, increasingly integrated with contrast agents for molecular insights. MSI uniquely combines spatial localization with molecular specificity, expanding its role in proteomics and metabolomics. Each type contributes a distinct value proposition, influencing adoption rates and pricing structures, thereby shaping the composite market taxonomy of Tissue Imaging.